kentucky medicaid pharmacy provider manual

kentucky medicaid pharmacy provider manual

We want to work with you to provide timely, safe and effective health care to our members. On this site, however, you’ll also find: Aetna Better Health of Kentucky is not responsible or liable for non-Aetna Better Health content, accuracy, or privacy practices of linked sites, or for products or services described on these sites. Good for you. Coding Corner Can Help Use the navigation on the left to quickly find what you're looking for. Be sure to check back frequently for updates. Email messages and any documents containing PHI are protected by various state and federal laws including 45 C.F.R. Part 164. No emails or documentation should be sent to this inbox that contain PHI unless the communication is encrypted. Examples of PHI include a member’s name, date of birth, any detail regarding their medical condition including diagnoses and any other combination of identifiable information. If you suspect another provider or member has committed fraud, waste or abuse, you have a responsibility and a right to report it. After your report is made, we will work to detect, correct and prevent fraud, waste, and abuse in the health care system. These SNP plans provide benefits beyond Original Medicare, and may include transportation to medical appointments and vision exams. Members must have Medicaid to enroll. You can also learn more about fax number retirement updates and other important updates. We’re taking the following actions to help those who may be affected by severe weather. This document contains information on effective dates by state and frequently asked questions. You can also learn more about fax number retirement updates and other important updates. We’re taking the following actions to help those who may be affected by severe weather. This document contains information on effective dates by state and frequently asked questions. View our updated HIPAA information for UnitedHealthcare Community Plan. View our policy.

• kentucky medicaid pharmacy provider manual, kentucky medicaid pharmacy manual, kentucky medicaid pharmacy provider manual, kentucky medicaid pharmacy provider manual template, kentucky medicaid pharmacy provider manual instructions, kentucky medicaid pharmacy provider manual form, kentucky medicaid pharmacy provider manual number, kentucky medicaid pharmacy provider manual.

To see updated policy changes, select the Bulletin section at left. For costs and complete details of coverage, call or write Humana or your Humana insurance agent or broker.Individual applications are subject to eligibility requirements.Before applying for group coverage, please refer to the pre-enrollment disclosures for a description of plan provisions which may exclude, limit, reduce, modify or terminate your coverage. Kentucky Medicaid Pharmacy and Therapeutics Information, opens new window. Medicaid provides healthcare coverage for income-eligible children, seniors, disabled adults, pregnant women and other eligible adults. Some plans may also charge a one-time, non-refundable enrollment fee. Some plans may also charge a one-time, non-refundable enrollment fee. For providers and practitioners, the process to obtain criteria is communicated annually in the provider newsletter and in the provider manual.Below are several helpful resources that may provide additional guidance and information.A prior authorization (PA) shall be honored by the Humana Health Plan for 90 days or until the recipient or provider is contacted by the Humana Health Plan regarding the PA. For Arizona residents: Insured by Humana Insurance Company. Administered by Humana Insurance Company.Humana Individual dental plans are insured or offered by Humana Insurance Company, HumanaDental Insurance Company, Humana Insurance Company of New York, The Dental Concern, Inc., CompBenefits Insurance Company, CompBenefits Company, CompBenefits Dental, Inc., Humana Employers Health Plan of Georgia, Inc., Humana Health Benefit Plan of Louisiana, Inc., Discount plans offered by HumanaDental Insurance Company or Humana Insurance Company. Please refer to the following for more information:“Humana” is the brand name for plans, products and services provided by one or more of the subsidiaries and affiliate companies of Humana Inc. (“Humana Entities”). Generic drug: Lowercase in plain type.

If the recipient and provider are not contacted by Humana Health Plan, the existing Medicaid PA shall be honored until expired.Except where noted preauthorization requests for medical services may be initiated:Except where noted, preauthorization requests for professionally administered medications may be initiated:Except where noted, preauthorization requests for pharmacy medications may be initiated:Starting Jan. 1, 2020, Humana Pharmacy Solutions began managing the pharmacy network for Humana’s Medicaid managed care plan in Kentucky. Administered by Humana Insurance Company.Humana Individual dental plans are insured or offered by Humana Insurance Company, HumanaDental Insurance Company, Humana Insurance Company of New York, The Dental Concern, Inc., CompBenefits Insurance Company, CompBenefits Company, CompBenefits Dental, Inc., Humana Employers Health Plan of Georgia, Inc., Humana Health Benefit Plan of Louisiana, Inc., Discount plans offered by HumanaDental Insurance Company or Humana Insurance Company. Referral to Medicaid Case Management Form, PDF opens new window. Brand name drug: Uppercase in bold type. In Medicaid, the list of covered drugs is determined by CMS and is based on whether the manufacturer agrees to pay the federally mandated Medicaid drug rebate. Department for Medicaid Services. Plans, products, and services are solely and only provided by one or more Humana Entities specified on the plan, product, or service contract, not Humana Inc. Not all plans, products, and services are available in each state.Humana group medical plans are offered by Humana Medical Plan, Inc., Humana Employers Health Plan of Georgia, Inc., Humana Health Plan, Inc., Humana Health Benefit Plan of Louisiana, Inc., Humana Health Plan of Ohio, Inc., Humana Health Plans of Puerto Rico, Inc. For Arizona residents, plans are offered by Humana Health Plan, Inc.For the 90 Day Supply at Retail Medication List, click here.

You can call us: You can call us: Stay tuned for more updates. Stay tuned for more updates. ATENCION: si habla espanol, tiene a su disposicion servicios gratuitos de asistencia linguistica. It does not contain individual state statutes created in 2009-2018. Recent state legislation related to Medicaid prescription drugs generally is designed around new or expanded applications of management tools already available to states through federal law. Among the strategies receiving legislative attention are use of: Several laws focus on altering the mix of drugs prescribed, either through broadened generic substitution or through creation of preferred drug lists (PDL) and the use of prior authorization (PA). UT Medicaid Report to the LFA - High Cost Drugs 2018-06 They now include the percentage change in spending on drugs per dosage unit and includes an expanded list of drugs. Some of the most commonly used drugs across Medicare Part B, Medicare Part D, and Medicaid saw double-digit annual increases over the last few years. A few examples are highlighted in the tables below.Published by GAO as GAO-18-528. Jul 26, 2018. Uniform PDL requirements are state prescribed requirements for designating a specified drug product as either preferred or non-preferred. - Published by Kaiser State Health Facts, 2018). Yes: Indicates that state had uniform clinical protocols in MCO contracts as of the specified year. - Published by Kaiser State Health Facts, 2018) Uninsured people who gained private coverage filled, on average, 28 percent more prescriptions and had 29 percent less out-of-pocket spending per prescription in 2014 compared to 2013.These changes include: In the past, states and federal Medicaid shared those savings. But under the new law, the federal government will keep all rebates within that 8-percentage-point range.The maximum copayment that Medicaid may charge is based on what the state pays for that service, as described in the following table.

Many States have received CMS approval on their State Plan Amendments to enter into single-State and multi-State supplemental drug rebate pools that generate rebates that are at least as large as the rebates set forth in the national rebate agreement with drug manufacturers.Issue brief, PDF -19pp.CMS has compiled a list of programs that meet the criteria to be considered SPAPs, titled Medicaid SPAP Best Price List.The number of states charging premiums or enrollment fees (30 states) or copayments (26 states) for children remained the same during 2015. While most states charge nominal copayments for parents (40 states) and expansion adults (23 of 31 expansion states), states generally do not charge these groups premiums given that most of these individuals have incomes below poverty. However, as of January 2016, five states (Arkansas, Indiana, Iowa, Michigan, and Montana) charge adults monthly contributions or premiums under Section 1115 waiver authority. Indiana also received approval to charge parents monthly contributions and, under separate Section 1916 waiver authority, to charge parents and adults higher cost-sharing for non-emergency use of the emergency room than otherwise allowed under federal law. Read Full Report, from Kaiser, January 2016. The brief was prepared by researchers at the Foundation and Avalere Health.Approximately 600 drug manufacturers currently participate in this program. All fifty States and the District of Columbia cover prescription drugs under the Medicaid Drug Rebate Program. The amount of rebate due for each unit of a drug is based on statutory formulas as follows: Note that some enacted state laws required subsequent federal action or approval, and therefore may not be in operation. This report does not include proposed bills which have not been passed or signed into law, nor actions relalted to the Affordable Care Act (ACA).

Under existing law, a privilege tax is imposed on each provider of pharmaceutical services at a rate of 10 cents for each prescription with a retail price of three dollars.If the department develops a preferred drug list to improve the Medicaid program's efficiency, it is the legislature's intent that the department should work with providers to develop the preferred drug list and that the department should establish an authorization system that is minimally intrusive to the providers while protecting access to medically necessary medications. The legislature encourages the department to develop case management systems or tools that allow for the comparison of cost savings associated with a preferred drug list or alternative cost containment methodologies. The cost containment measures taken may include new utilization review procedures, changes in provider payment rates, and negotiation for federal coverage under Indian Health or Medicare.Drugs approved for the PDL will be selected based on clinical effectiveness, safety and costs. The Department will phase in the PDL by sets of drug classes. It deletes a previous law that provided that a new drug designated by the FDA as having an important therapeutic gain shall be immediately included on the list of contract drugs for 3 years.The provisions do not apply to AIDS, cancer or mental health drugs.The voluntary drug discount program includes: 1) individuals with annual income to 300% of the federal poverty guidelines, 2) persons or families facing extraordinary medical expenses equal to at least 10 percent of annual income, or 3) is enrolled in the Medicare Program, but whose prescription drugs are not covered by the Medicare Program. The use of prior authorization option takes effect August 2010.Prior authorization is required for individuals requiring nine or more pharmaceuticals.

The Department will contract with any pharmacist within the State who is licensed in good standing; assistance must be provided within ten days of a request.Requires at least an annual review and update of the Maximum Allowable Cost (MAC) list for Medicaid.Current law generally requires prior authorization for brand name drugs under Medicaid or ConnPACE if a generic drug is available at a lower cost.The legal authority for the program comes from two sections of federal law.The purpose of this program is to control duplicate and inappropriate drug therapies. Any patient is eligible for this lock-in. Patients most likely to benefit from this service are those who see multiple physicians with complicated drug regimens If the federal government increases the federal Medicaid match, persons aged 65 or over with incomes up to 150% of poverty will be eligible. Authorizes submission of a section 1115 waiver request.This increase is directly tied to the new Pharmacy Plus program described above.Limits to access of drugs under this program may be done so to the extent restrictions are in place in the Medicaid program. The waiver must limit the state expenditures to funding appropriated to the Indiana prescription drug account established from the Indiana tobacco settlement fund.Limit number of brand name prescriptions to four brand names per month. Expand Indiana Rational Drug Program. This program applies prior authorization to drug classes. Expand the Over-the-Counter Formulary. Limit prescriptions to a 34-day supply for most medications. The purpose is to reduce waste and abuse.Those drugs not on the PDL will be subject to prior authorization, with drugs used to treat mental illness exempt from prior authorization. In addition, the Department may limit reimbursement to the generic drug unless the prescriber indicates brand name necessary.Children, pregnant women, and institutionalized people continue to be exempt from copayments.

The report previously included information on dispensing fee costs and drug acquisition costs, the current level of dispensing fee provided by the cabinet and other third-party payors, and an estimate of any additional revenues needed to adjust reimbursement to pharmacies.Requires patients to be informed of, and consent to, the equivalent drug product interchange. Failure to abide by these provisions can result in a fine and refusal, suspension or revocation of license. In 2002, Department of Health and Hospitals announced that it is establishing a six-to-eight prescription per month limit for Medicaid recipients. Extra prescriptions can be obtained through the prior approval process.In 2002 Maine lowered the Medicaid ingredient reimbursement basis from AWP -10% to AWP-13%.Craven (2004) If the federal waiver is approved, any Medicare beneficiary without drug coverage will be eligible to enroll and will receive a discount on purchases tied to the Medicaid price less rebates. If the waiver is not approved, the Pharmacy Discount Program will be run as part of the existing state Pharmacy Assistance Program. The discount will be tied to the Pharmacy Assistance Program prices less rebates. Persons with incomes at or below 175% will receive a subsidy of 25% of the costs.The law allows the Department to implement cost containment measures including generic drugs, the use of tiered copayments as long as it does not result in an increase in total copayment collections, and the use of differential dispensing fees to pharmacies. The Department may not reduce the pharmacy reimbursement rate until October 1, 2002.The state is authorized to use supplemental rebates in connection with the PDL. To further encourage this shift the Department is implementing two pharmacy dispensing fees, one fee for brand name drugs not on the preferred drug list and a higher fee for generic drugs or drugs on the preferred drug list.Brand name alternatives require prior authorization.

Products only available as brand-name products do not require authorization for the first half of 2002. The agency implemented a product-specific prior authorization drug list as of July 2002. In May 2003, a state Superior Court judge struck down the provider tax as illegal because state regulators failed to get the required federal approval. Mortimer; Sen. Goguen S Hammerstrom Cherry (2006) Limits each prescription to a 34-day supply.After enactment the state was advised they cannot use a closed formulary, so they are considering a preferred drug list. Removes requirement requiring prior approval for every prescription over five per month.Also establishes a mandatory preferred drug list (PDL) coupled with a prior authorization program for non-preferred products. Authorizes a partnership with another state to use bulk purchasing power to negotiate lower acquisition costs. Authorizes agreements and negotiations with other countries to facilitate the acquisition of prescription drugs, if allowed by federal law and if it will lower the acquisition costs of those drugs. Modeled after the Florida program, this law increases the prescription limits to four brand names plus unlimited generics.It also covers people with disabilities over age 18 and those eligible for state mental health services.The bill specifies the composition of a pharmacy and therapeutics committee to advise the Medicaid agency on medications subject to prior authorization, criteria for medical necessity to be used in a prior authorization program, and criteria for lock-in programs to prevent unauthorized multiple refills.Wendelboe (2006) However, the Commissioner of Health is allowed to exempt any brand name drug from this restriction.Provides that any doctor or prescriber may specify and prescribe a non-preferred drug if they notify the state Department by telephone; such requests cannot be denied.

Hannon (2006) The first list was scheduled to be phased in beginning December 2002, but the plan is on hold indefinitely in 2003. The 15-member board shall review all drugs to be placed on prior authorization, with an annual review of the list required.Examples may include disease management, drug product donations, drug utilization control, beneficiary counseling, and fraud and abuse initiatives. Also requires the agency to examine instituting a copayment program, and to seek federal waivers if appropriate.Requires Department of Human Services to apply to federal government for waiver to allow copayments.Establishes a Waiver Application Steering Committee including four legislators to assist and advise the department.Provider cannot refuse service to a patient due to the patient's inability to pay. Reimbursement: Effective September 1, 2002, payment for eligible prescription drugs will be made to pharmacies at Average Wholesale Price (AWP) less 14%, changed from AWP-13%.The program includes state-negotiated supplemental rebates. In 2004 The Department of Health and Human Services began implementation of the Medicaid Preferred Drug List, including several phases involving an additional set of therapeutic classes to be included on the PDL, building on the existing prior authorization (PA) program. Phase I implementation began July 21, 2004. The state is also negotiating supplemental rebates with pharmaceutical companies and creating an enhanced prior authorization program for South Carolina Medicaid pharmacy services. BeBerry (2007) DuBois, Rep. Odom (2007) Kyle (2007) Would create a system of bulk purchasing of prescription drugs by state agencies, including Dept.As of September 2004 eight states had join this project.) The program's consumer protections permit the patient's doctor to require the dispensing of a higher cost drug if the lower cost drug is not effective or may result in adverse reactions.The start date is September 1, 2002.

This SeniorCare Program is described as intended to save costs by delaying seniors' enrollment in Medicaid. The pool shall consist of the state and any eligible party that satisfies the conditions established for joining the pool.To encourage the use of lower-cost drugs, states may establish different copayments for generic versus brand-name drugs or for drugs included on a preferred drug list. For people with incomes above 150% FPL, copayments for non-preferred drugs may be as high as 20 percent of the cost of the drug. For people with income at or below 150% FPL, copayments are limited to nominal amounts. States must specify which drugs are considered either “preferred” or “non-preferred.” States also have the option to establish different copayments for mail order drugs and for drugs sold in a pharmacy. See more information on Prescription Drugs. Please note the dates listed for individual entries. Some items, including statutes and policies, may no longer be current. Utah has expanded and clarified use of preferred drug lists. Utah passed a law expanding use of 340B discounts through Medicaid. The rules were to implement certain provisions of the Deficit Reduction Act (DRA) that was enacted February 8,2006. The delay moves the effective date from December 31, 2009 until July 1, 2010 allowing time to revise a substantial portion of the final rule based on a review and consideration of provisions in the Children’s Health Insurance Program Reauthorization Act (CHIPRA), enacted February 4, 2009, and the American Recovery and Reinvestment Act of 2009 (ARRA), enacted February 17, 2009. Certain provisions in CHIPRA amend Section 1937 by requiring that states provide the full range of Early Periodic Screening, Diagnosis, and Treatment (EPSDT) coverage benefit to children under the age of 21, rather than those under 19 as specified in the DRA, who are enrolled in benchmark or benchmark-equivalent plans.

In addition, provisions in ARRA amend Section 1916A of the Social Security Act which was added by the DRA. The DRA had amended the Social Security Act by adding language which provides state Medicaid agencies increased flexibility to impose premiums and cost sharing requirements on certain Medicaid recipients. Earlier this year ARRA prohibited the imposing of premiums or other cost sharing payments on Indians who received services under a state Medicaid plan by Indian health providers or through referral under contract health services. The final rule may be found in the Federal Register at. This provision (amending Section 7002(b) of the Social Security Act) was intended as an anti-fraud measure, and was scheduled to take effect on October 1, 2007. Advocates and pharmacists alike feared that Medicaid beneficiaries would be unable to fill prescriptions in the many states that had not taken the necessary steps to meet this new requirement. On September 20, over 90 members of Congress requested a delay in implementation of the tamper proof prescription pad requirement, in response to a joint education effort by pharmacists and advocates. H.R. 3668 included a provision delaying implementation of the tamper resistant prescription pad mandate until March 31, 2008; it passed both Houses of Congress and was signed into law on September 29, 2007. See notes below for lawsuits related to Florida, Maine and Michigan. Not all measures listed are in effect in 2007. For example a 2002 Oklahoma law establishes a detailed set of requirements that must be met before any new decisions are made to require prior authorization. A 2001 Oregon law established a preferred drug list, but allows individual physicians to make final decisions and does not require prior authorization. The first state approval, for Illinois, provides a federal dollar match, with the state providing 50% of the cost.

As of late April 2003, Florida, Indiana, Illinois, Maryland, South Carolina and Wisconsin have approved waivers. These programs were phased out after implementation of the federal Medicare Part D benefits. The court decision rejected legal claims brought by manufacturers, and permits the Michigan program, and similar laws in at least a dozen states, to remain in place. In December a Michigan state court also ruled in favor of the program. Because of potential impacts on laws in other states, NCSL has additional materials about the Michigan program: New executive branch initiatives for multi-state purchasing are being implemented in Michigan, South Carolina, Vermont and Wisconsin, while new regulations in Alabama, Maryland, Massachusetts and New York affect preferred drug lists and fees. Alaska, South Carolina, and Wyoming worked to implement Medicaid Preferred Drug List programs. The National Medicaid Buying Pool has expanded to include Hawaii, Montana and Tennessee. In addition to documenting policy actions states implemented in the fiscal year that just ended, each survey also documents policy actions adopted for the fiscal year that just began in most states (i.e. the report cited for the SFY 2017 data asked about policy actions implemented in SFY 2017 and policy actions adopted for SFY 2018). Data on adopted policy actions for FY 2018 can be found in the Final Reports of all Medicaid Budget Surveys, but are not included on this site because adopted policies are sometimes delayed or not implemented for reasons related to legal, fiscal, administrative, systems, or political considerations, or due to delays in approval from CMS. Beginning in 2014, the survey was completed through a partnership with the the National Association of Medicaid Directors (NAMD). Final Reports of all Medicaid Budget Surveys are available on the following archive page.

Covered Entities rely on Contract Pharmacies to dispense 340B Program discounted medication to eligible patients in situations where the Covered Entity does not own a pharmacy or otherwise requires pharmacy services to supplement Covered Entity-owned pharmacies. In recent years, 340B Covered Entities have begun to heavily rely on Contract Pharmacies both to enable Covered Entities to access 340B Program discounts and to provide services to as many eligible Covered Entity patients as possible. In this context, a number of state Medicaid agency proposals have failed to consider the effect they may have on patients’ access to health care, safety net provider financial stability, and in some circumstances, whether the proposed changes comply with applicable federal law. Further, Kentucky’s proposal appears to disregard Federal law and guidance stating that the written agreement requirement may apply only to 340B Program drugs dispensed to FFS patients. 3 Further, the financial ramifications of the proposal may likely force Covered Entities into making difficult decisions about whether to cut 340B Program-dependent clinical service lines that their patients rely upon.If not, you're missing attorney insights on issues and regulations impacting business. Bonaventure University St. Louis Wayne State University Wayne State University Law School Wesley Biblical Seminary West Virginia University West Virginia University College of Law West Virginia Wesleyan College Western Kentucky University Western Maryland College, now known as McDaniel College Western Michigan University Cooley Law School Western Michigan University Thomas M.

Cooley Law School Westminster College Wheaton College Wheeling Jesuit University Widener School of Law William and Mary School of Law Williams College Wilmington College Wittenberg University Wright State University Xavier University Yale Law School Yale University Divinity School Yonsei University, South Korea York University Schulich School of Business, Toronto Youngstown State University More. Let’s clarify a few things. It is intended to be an informative guide, and not a comprehensive legal resource. Always consult with your local team of experts and administrators. Kentucky is one of only two state Medicaid programs that allow chiropractors to bill for telemedicine. This means that private payers in this state are legally obligated to cover telemedicine services the same as in-person medical services. Fortunately, with all health providers except Speech language pathologists, a telemedicine visit can be used to establish that provider-patient relationship. Kentucky law allows good faith prior examinations to be performed through a telehealth service. You can read more about how to do telemedicine-specific patient informed consent here. Kentucky isn’t part of the Interstate medical license compact yet. To bill for telemedicine, use the appropriate CPT code, along with GT modifier to note telemedicine delivery. See your Medicaid Provider Manual for more details. Check them out for more details on your state’s policy! See why the largest systems in the US choose eVisit.http://ersanteknoloji.com/images/canon-ipf5100-manual-pdf.pdf